Australia In Vitro Diagnostics Market Outlook to 2016

Introduction

GlobalData’s new report, “Australia In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Australia In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Market size and company share data for In Vitro Diagnostics (IVD) market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016.
- 2009 company shares and distribution shares data for each of the seven market categories.
- Global corporate-level profiles of key companies operating within the Australia In Vitro Diagnostics (IVD) market.
- Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, and Becton, Dickinson.

Highlights

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Australia In Vitro Diagnostics (IVD) competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Report Highlights
F. Hoffmann-La Roche Ltd.
Siemens Healthcare
Abbott Laboratories
Beckman Coulter, Inc.
Sysmex Corporation
bioMerieux S.A.
Dade Behring Holdings, Inc.
OLYMPUS CORPORATION
Inverness Medical Innovations, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Hologic, Inc.
Digene Corporation
Ventana Medical Systems, Inc.
Ortho-Clinical Diagnostics Inc.
DiaSorin S.p.A
Qiagen N.V.
Gen-Probe Incorporated
Phadia AB
Black Ridge Mining Limited
Roche Diagnostics Australia Pty. Ltd.
Diagnostic Technology Pty Ltd
Anteo Diagnostics Limited
Cellestis Limited
NuSep Ltd
Vision BioSystems Ltd
Holista CollTech Limited
Tyrian Diagnostics Limited
LabTech Systems Limited
Rockeby Biomed Limited
Universal Biosensors, Inc.
GeneWorks Pty. Ltd.
Astral Scientific Pty Ltd
Banksia Scientific Pte Ltd
Enterix Australia Pty Ltd
HealthLinx Limited
Panbio Limited
Genera Biosystems Limited
Quintain NanoSystems
Mosaic Medical (Asia Pacific) Pty Ltd
Australasian Medical & Scientific Limited
TGR BioSciences Pty Ltd
[Fade out the market survey infos]

TABLE OF CONTENTS

1 Table of Contents 2
1.1 List of Tables 10
1.2 List of Figures 13
2 Introduction 16
2.1 What is This Report About? 16
3 In Vitro Diagnostics In Australia 17
3.1 In Vitro Diagnostics, Market Segmentation 17
3.2 In Vitro Diagnostics, Australia, Overall Revenue ($m), 2002-2016 18
3.3 In Vitro Diagnostics Market, Australia, Revenue Mix ($m), 2009 20
3.4 In Vitro Diagnostics Market, Australia, Category Contribution (%), 2009 21
3.5 In Vitro Diagnostics, Australia, Company Share (2008-2009) 27
4 Clinical Chemistry In Australia 28
4.1 Clinical Chemistry, Market Segmentation 28
4.2 Clinical Chemistry Market, Australia, Revenue Mix ($m), 2009 29
4.3 Clinical Chemistry Market, Australia, Category Contribution (%), 2009 30
4.4 Clinical Chemistry Overall Revenue (2002-2016) 31
4.4.1 Clinical Chemisty Analyzers Revenue (2002-2016) 35
4.4.2 Urine Analysis Revenue (2002-2016) 39
4.5 Clinical Chemistry Distribution Share (2008-2009) 41
4.6 Clinical Chemistry, Australia, Company Share (2008-2009) 42
5 Genetic Testing In Australia 44
5.1 Genetic Testing, Market Segmentation 44
5.2 Genetic Testing Market, Australia, Revenue Mix ($m), 2009 45
5.3 Genetic Testing Market, Australia, Category Contribution (%), 2009 46
5.4 Genetic Testing Overall Revenue (2002-2016) 47
5.5 Genetic Testing Distribution Share (2008-2009) 51
5.6 Genetic Testing, Australia, Company Share (2008-2009) 52
6 Haematology In Australia 53
6.1 Haematology, Market Segmentation 53
6.2 Haematology Market, Australia, Revenue Mix ($m), 2009 54
6.3 Haematology Market, Australia, Category Contribution (%), 2009 55
6.4 Haematology Overall Revenue (2002-2016) 56
6.4.1 Haematology Reagents Revenue (2002-2016) 60
6.4.2 Immunohaematology Revenue (2002-2016) 62
6.4.3 Haemostasis Revenue (2002-2016) 64
6.4.4 Haematology Rapid Tests Revenue (2002-2016) 68
6.4.5 Haematology Cell Counters Revenue (2002-2016) 72
6.5 Haematology Distribution Share (2008-2009) 74
6.6 Haematology, Australia, Company Share (2008-2009) 75
7 Histology And Cytology In Australia 77
7.1 Histology and Cytology, Market Segmentation 77
7.2 Histology and Cytology Market, Australia, Revenue Mix ($m), 2009 78
7.3 Histology and Cytology Market, Australia, Category Contribution (%), 2009 79
7.4 Histology and Cytology Overall Revenue (2002-2016) 80
7.4.1 Histology Revenue (2002-2016) 83
7.5 Histology and Cytology Distribution Share (2008-2009) 85
7.6 Histology and Cytology, Australia, Company Share (2008-2009) 86
8 Immuno Chemistry In Australia 87
8.1 Immuno Chemistry, Market Segmentation 87
8.2 Immuno Chemistry Market, Australia, Revenue Mix ($m), 2009 88
8.3 Immuno Chemistry Market, Australia, Category Contribution (%), 2009 89
8.4 Immuno Chemistry Overall Revenue (2002-2016) 90
8.4.1 Disease Specific Immunochemistry Revenue (2002-2016) 94
8.4.2 Drug Related Testing Revenue (2002-2016) 98
8.4.3 Endocrinology Tests Revenue (2002-2016) 100
8.4.4 Immunochemistry Analyzers Revenue (2002-2016) 104
8.5 Immuno Chemistry Distribution Share (2008-2009) 108
8.6 Immuno Chemistry, Australia, Company Share (2008-2009) 109
9 Infectious Immunology In Australia 111
9.1 Infectious Immunology, Market Segmentation 111
9.2 Infectious Immunology Market, Australia, Revenue Mix ($m), 2009 112
9.3 Infectious Immunology Market, Australia, Category Contribution (%), 2009 113
9.4 Infectious Immunology Overall Revenue (2002-2016) 114
9.5 Infectious Immunology Distribution Share (2008-2009) 118
9.6 Infectious Immunology, Australia, Company Share (2008-2009) 119
10 Microbiology Culture In Australia 121
10.1 Microbiology Culture, Market Segmentation 121
10.2 Microbiology Culture Market, Australia, Revenue Mix ($m), 2009 122
10.3 Microbiology Culture Market, Australia, Category Contribution (%), 2009 123
10.4 Microbiology Culture Overall Revenue (2002-2016) 124
10.4.1 Microbiology Analyzers Revenue (2002-2016) 128
10.5 Microbiology Culture Distribution Share (2008-2009) 130
10.6 Microbiology Culture, Australia, Company Share (2008-2009) 131
11 Overview of Key Companies in Australia In Vitro Diagnostics Market 132
11.1 F. Hoffmann-La Roche Ltd. 132
11.1.1 Company Overview 132
11.1.2 Share in the Australia In Vitro Diagnostics Market 132
11.2 Siemens Healthcare 133
11.2.1 Company Overview 133
11.2.2 Share in the Australia In Vitro Diagnostics Market 133
11.3 Abbott Laboratories 134
11.3.1 Company Overview 134
11.3.2 Share in the Australia In Vitro Diagnostics Market 134
11.4 Beckman Coulter, Inc. 135
11.4.1 Company Overview 135
11.4.2 Share in the Australia In Vitro Diagnostics Market 135
11.5 Sysmex Corporation 136
11.5.1 Company Overview 136
11.5.2 Share in the Australia In Vitro Diagnostics Market 136
11.6 bioMerieux S.A. 137
11.6.1 Company Overview 137
11.6.2 Share in the Australia In Vitro Diagnostics Market 137
11.7 Dade Behring Holdings, Inc. 138
11.7.1 Company Overview 138
11.8 OLYMPUS CORPORATION 138
11.8.1 Company Overview 138
11.9 Inverness Medical Innovations, Inc. 138
11.9.1 Company Overview 138
11.10 Becton, Dickinson and Company 139
11.10.1 Company Overview 139
11.11 Bio-Rad Laboratories, Inc. 139
11.11.1 Company Overview 139
11.12 Hologic, Inc. 140
11.12.1 Company Overview 140
11.13 Digene Corporation 140
11.13.1 Company Overview 140
11.14 Ventana Medical Systems, Inc. 140
11.14.1 Company Overview 140
11.15 Ortho-Clinical Diagnostics Inc. 141
11.15.1 Company Overview 141
11.16 DiaSorin S.p.A 141
11.16.1 Company Overview 141
11.17 Qiagen N.V. 141
11.17.1 Company Overview 141
11.18 Gen-Probe Incorporated 142
11.18.1 Company Overview 142
11.19 Phadia AB 142
11.19.1 Company Overview 142
11.20 Black Ridge Mining Limited 143
11.20.1 Company Overview 143
11.21 Roche Diagnostics Australia Pty. Ltd. 143
11.21.1 Company Overview 143
11.22 Diagnostic Technology Pty Ltd 143
11.22.1 Company Overview 143
11.23 Anteo Diagnostics Limited 144
11.23.1 Company Overview 144
11.24 Cellestis Limited 144
11.24.1 Company Overview 144
11.25 NuSep Ltd 144
11.25.1 Company Overview 144
11.26 Vision BioSystems Ltd 145
11.26.1 Company Overview 145
11.27 Holista CollTech Limited 145
11.27.1 Company Overview 145
11.28 Tyrian Diagnostics Limited 145
11.28.1 Company Overview 145
11.29 LabTech Systems Limited 146
11.29.1 Company Overview 146
11.30 Rockeby Biomed Limited 146
11.30.1 Company Overview 146
11.31 Universal Biosensors, Inc. 146
11.31.1 Company Overview 146
11.32 GeneWorks Pty. Ltd. 147
11.32.1 Company Overview 147
11.33 Astral Scientific Pty Ltd 147
11.33.1 Company Overview 147
11.34 Banksia Scientific Pte Ltd 147
11.34.1 Company Overview 147
11.35 Enterix Australia Pty Ltd 147
11.35.1 Company Overview 147
11.36 HealthLinx Limited 148
11.36.1 Company Overview 148
11.37 Panbio Limited 148
11.37.1 Company Overview 148
11.38 Genera Biosystems Limited 148
11.38.1 Company Overview 148
11.39 Quintain NanoSystems 149
11.39.1 Company Overview 149
11.40 Mosaic Medical (Asia Pacific) Pty Ltd 149
11.40.1 Company Overview 149
11.41 Australasian Medical & Scientific Limited 149
11.41.1 Company Overview 149
11.42 TGR BioSciences Pty Ltd 150
11.42.1 Company Overview 150
12 In Vitro Diagnostics Market Pipeline Products 151
12.1 Clinical Chemisty Market Pipeline Products 151
12.2 Immuno Chemistry Market Pipeline Products 153
12.3 Haematology Market Pipeline Products 154
12.4 Infectious Immunology Market Pipeline Products 155
12.5 Microbiology Culture Market Pipeline Products 157
12.6 Histology and Cytology Market Pipeline Products 158
12.7 Genetic Testing Market Pipeline Products 159
13 Financial Deals Landscape 161
13.1 Partnerships 161
13.1.1 QIAGEN Enters Into Distribution Agreement With Celera 161
13.1.2 Sequenom Enters Into Licensing Agreement With Optherion 162
13.1.3 QIAGEN Enters Into Licensing Agreement With Johns Hopkins University 163
13.1.4 Rubicon Genomics Enters Into Agreement With ZyGEM 164
13.1.5 OraSure Technologies Enters Into An Agreement With Roche Diagnostics 165
13.1.6 Anteo Diagnostics Enters Into Licensing Agreement With Bangs Laboratories 166
13.1.7 Response Genetics Enters Into Distribution Agreement With Genetic Technologies 167
13.1.8 Inverness Medical Innovations Enters Into Distribution Agreement With Epocal 168
13.1.9 Celera Enters Into Licensing Agreement With Medical Therapies 169
13.1.10 Rosetta Genomics Enters Into An Agreement With Genetic Technologies 170
13.2 Recent Developments 171
13.3 Government and Public Interest 171
13.3.1 Apr 27, 2010: New Diagnostic Kit To Improve Health Outcomes For HIV Patients 171
13.3.2 Aug 19, 2009: Quick And Accurate Way Of Diagnosing Endometriosis 171
13.4 Product News 173
13.4.1 Apr 05, 2010: PinPointe Launches PinPointe FootLaser Treatment In Australia 173
13.4.2 Jan 22, 2010: Genera Biosystems Announces TGA Approval For PapType HPV Detection And Genotyping Test 173
14 Appendix 175
14.1 Definitions of Markets Covered in the Report 176
14.1.1 In Vitro Diagnostics 176
14.2 Research Methodology 184
14.3 Secondary Research 185
14.4 Primary Research 185
14.5 Models 186
14.6 Forecasts 186
14.7 Expert Panels 186
14.8 GlobalData Consulting 186
14.9 Currency Conversion 187
14.10 Contact Us 187
14.11 Disclaimer 187
[Fade out table of contents]

LIST OF TABLES

1.1 List of Tables
Table 1: In Vitro Diagnostics, Australia, Overall Revenue ($m), 2002-2016 19
Table 2: In Vitro Diagnostics Market, Australia, Category Contribution (%), 2009 21
Table 3: In Vitro Diagnostics, Australia, Cross-Category Analysis, 2002-2016 22
Table 4: In Vitro Diagnostics, Australia, Overall Revenue ($m), Historic, 2002-2009 24
Table 5: In Vitro Diagnostics, Australia, Overall Revenue ($m), Forecast, 2009-2016 26
Table 6: In Vitro Diagnostics, Australia, Company Share by Revenue ($m), 2008-2009 27
Table 7: Clinical Chemistry Market, Australia, Category Contribution (%), 2009 30
Table 8: Clinical Chemistry, Australia, Revenue ($m) by Segment, Historic, 2002-2009 32
Table 9: Clinical Chemistry, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 34
Table 10: Clinical Chemisty Analyzers, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 36
Table 11: Clinical Chemisty Analyzers, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 38
Table 12: Urine Analysis, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 39
Table 13: Urine Analysis, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 40
Table 14: Clinical Chemistry, Australia, Distribution Share by Revenue ($m), 2008-2009 41
Table 15: Clinical Chemistry, Australia, Company Share by Revenue ($m), 2008-2009 42
Table 16: Genetic Testing Market, Australia, Category Contribution (%), 2009 46
Table 17: Genetic Testing, Australia, Revenue ($m) by Segment, Historic, 2002-2009 48
Table 18: Genetic Testing, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 50
Table 19: Genetic Testing, Australia, Distribution Share by Revenue ($m), 2008-2009 51
Table 20: Genetic Testing, Australia, Company Share by Revenue ($m), 2008-2009 52
Table 21: Haematology Market, Australia, Category Contribution (%), 2009 55
Table 22: Haematology, Australia, Revenue ($m) by Segment, Historic, 2002-2009 57
Table 23: Haematology, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 59
Table 24: Haematology Reagents, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 60
Table 25: Haematology Reagents, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 61
Table 26: Immunohaematology, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 62
Table 27: Immunohaematology, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 63
Table 28: Haemostasis, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 65
Table 29: Haemostasis, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 67
Table 30: Haematology Rapid Tests, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 69
Table 31: Haematology Rapid Tests, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 71
Table 32: Haematology Cell Counters, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 72
Table 33: Haematology Cell Counters, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 73
Table 34: Haematology, Australia, Distribution Share by Revenue ($m), 2008-2009 74
Table 35: Haematology, Australia, Company Share by Revenue ($m), 2008-2009 76
Table 36: Histology and Cytology Market, Australia, Category Contribution (%), 2009 79
Table 37: Histology And Cytology, Australia, Revenue ($m) by Segment, Historic, 2002-2009 81
Table 38: Histology And Cytology, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 82
Table 39: Histology, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 83
Table 40: Histology, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 84
Table 41: Histology And Cytology, Australia, Distribution Share by Revenue ($m), 2008-2009 85
Table 42: Histology And Cytology, Australia, Company Share by Revenue ($m), 2008-2009 86
Table 43: Immuno Chemistry Market, Australia, Category Contribution (%), 2009 89
Table 44: Immuno Chemistry, Australia, Revenue ($m) by Segment, Historic, 2002-2009 91
Table 45: Immuno Chemistry, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 93
Table 46: Disease Specific Immunochemistry, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 95
Table 47: Disease Specific Immunochemistry, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 97
Table 48: Drug Related Testing, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 98
Table 49: Drug Related Testing, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 99
Table 50: Endocrinology Tests, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 101
Table 51: Endocrinology Tests, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 103
Table 52: Immunochemistry Analyzers, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 105
Table 53: Immunochemistry Analyzers, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 107
Table 54: Immuno Chemistry, Australia, Distribution Share by Revenue ($m), 2008-2009 108
Table 55: Immuno Chemistry, Australia, Company Share by Revenue ($m), 2008-2009 110
Table 56: Infectious Immunology Market, Australia, Category Contribution (%), 2009 113
Table 57: Infectious Immunology, Australia, Revenue ($m) by Segment, Historic, 2002-2009 115
Table 58: Infectious Immunology, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 117
Table 59: Infectious Immunology, Australia, Distribution Share by Revenue ($m), 2008-2009 118
Table 60: Infectious Immunology, Australia, Company Share by Revenue ($m), 2008-2009 120
Table 61: Microbiology Culture Market, Australia, Category Contribution (%), 2009 123
Table 62: Microbiology Culture, Australia, Revenue ($m) by Segment, Historic, 2002-2009 125
Table 63: Microbiology Culture, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 127
Table 64: Microbiology Analyzers, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 128
Table 65: Microbiology Analyzers, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 129
Table 66: Microbiology Culture, Australia, Distribution Share by Revenue ($m), 2008-2009 130
Table 67: Microbiology Culture, Australia, Company Share by Revenue ($m), 2008-2009 131
Table 68: Clinical Chemisty Market Pipeline Products 151
Table 69: Immuno Chemistry Market Pipeline Products 153
Table 70: Haematology Market Pipeline Products 154
Table 71: Infectious Immunology Market Pipeline Products 155
Table 72: Microbiology Culture Market Pipeline Products 157
Table 73: Histology and Cytology Market Pipeline Products 158
Table 74: Genetic Testing Market Pipeline Products 159
Table 75: QIAGEN Enters Into Distribution Agreement With Celera 161
Table 76: Sequenom Enters Into Licensing Agreement With Optherion 162
Table 77: QIAGEN Enters Into Licensing Agreement With Johns Hopkins University 163
Table 78: Rubicon Genomics Enters Into Agreement With ZyGEM 164
Table 79: OraSure Technologies Enters Into An Agreement With Roche Diagnostics 165
Table 80: Anteo Diagnostics Enters Into Licensing Agreement With Bangs Laboratories 166
Table 81: Response Genetics Enters Into Distribution Agreement With Genetic Technologies 167
Table 82: Inverness Medical Innovations Enters Into Distribution Agreement With Epocal 168
Table 83: Celera Enters Into Licensing Agreement With Medical Therapies 169
Table 84: Rosetta Genomics Enters Into An Agreement With Genetic Technologies 170
Table 85: USD to Local Currency, Australia, Average Actual Rate 2002-2009 187
LIST OF FIGURES

1.2 List of Figures
Figure 1: In Vitro Diagnostics, Market Segmentation 17
Figure 2: In Vitro Diagnostics, Australia, Overall Revenue ($m), 2002-2016 18
Figure 3: In Vitro Diagnostics Market, Australia, Revenue Mix ($m), 2009 20
Figure 4: In Vitro Diagnostics Market, Australia, Category Contribution (%), 2009 21
Figure 5: In Vitro Diagnostics, Australia, Cross-Category Analysis, 2002-2016 22
Figure 6: In Vitro Diagnostics, Australia, Overall Revenue ($m), Historic, 2002-2009 23
Figure 7: In Vitro Diagnostics, Australia, Overall Revenue ($m), Forecast, 2009-2016 25
Figure 8: In Vitro Diagnostics, Australia, Company Share (%), 2009 27
Figure 9: Clinical Chemistry, Market Segmentation 28
Figure 10: Clinical Chemistry Market, Australia, Revenue Mix ($m), 2009 29
Figure 11: Clinical Chemistry Market, Australia, Category Contribution (%), 2009 30
Figure 12: Clinical Chemistry, Australia, Revenue ($m) by Segment, Historic, 2002-2009 31
Figure 13: Clinical Chemistry, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 33
Figure 14: Clinical Chemisty Analyzers, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 35
Figure 15: Clinical Chemisty Analyzers, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 37
Figure 16: Urine Analysis, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 39
Figure 17: Urine Analysis, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 40
Figure 18: Clinical Chemistry, Australia, Company Share (%), 2009 42
Figure 19: Genetic Testing, Market Segmentation 44
Figure 20: Genetic Testing Market, Australia, Revenue Mix ($m), 2009 45
Figure 21: Genetic Testing Market, Australia, Category Contribution (%), 2009 46
Figure 22: Genetic Testing, Australia, Revenue ($m) by Segment, Historic, 2002-2009 47
Figure 23: Genetic Testing, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 49
Figure 24: Genetic Testing, Australia, Company Share (%), 2009 52
Figure 25: Haematology, Market Segmentation 53
Figure 26: Haematology Market, Australia, Revenue Mix ($m), 2009 54
Figure 27: Haematology Market, Australia, Category Contribution (%), 2009 55
Figure 28: Haematology, Australia, Revenue ($m) by Segment, Historic, 2002-2009 56
Figure 29: Haematology, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 58
Figure 30: Haematology Reagents, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 60
Figure 31: Haematology Reagents, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 61
Figure 32: Immunohaematology, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 62
Figure 33: Immunohaematology, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 63
Figure 34: Haemostasis, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 64
Figure 35: Haemostasis, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 66
Figure 36: Haematology Rapid Tests, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 68
Figure 37: Haematology Rapid Tests, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 70
Figure 38: Haematology Cell Counters, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 72
Figure 39: Haematology Cell Counters, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 73
Figure 40: Haematology, Australia, Company Share (%), 2009 75
Figure 41: Histology and Cytology, Market Segmentation 77
Figure 42: Histology and Cytology Market, Australia, Revenue Mix ($m), 2009 78
Figure 43: Histology and Cytology Market, Australia, Category Contribution (%), 2009 79
Figure 44: Histology And Cytology, Australia, Revenue ($m) by Segment, Historic, 2002-2009 80
Figure 45: Histology And Cytology, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 82
Figure 46: Histology, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 83
Figure 47: Histology, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 84
Figure 48: Histology And Cytology, Australia, Company Share (%), 2009 86
Figure 49: Immuno Chemistry, Market Segmentation 87
Figure 50: Immuno Chemistry Market, Australia, Revenue Mix ($m), 2009 88
Figure 51: Immuno Chemistry Market, Australia, Category Contribution (%), 2009 89
Figure 52: Immuno Chemistry, Australia, Revenue ($m) by Segment, Historic, 2002-2009 90
Figure 53: Immuno Chemistry, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 92
Figure 54: Disease Specific Immunochemistry, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 94
Figure 55: Disease Specific Immunochemistry, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 96
Figure 56: Drug Related Testing, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 98
Figure 57: Drug Related Testing, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 99
Figure 58: Endocrinology Tests, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 100
Figure 59: Endocrinology Tests, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 102
Figure 60: Immunochemistry Analyzers, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 104
Figure 61: Immunochemistry Analyzers, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 106
Figure 62: Immuno Chemistry, Australia, Company Share (%), 2009 109
Figure 63: Infectious Immunology, Market Segmentation 111
Figure 64: Infectious Immunology Market, Australia, Revenue Mix ($m), 2009 112
Figure 65: Infectious Immunology Market, Australia, Category Contribution (%), 2009 113
Figure 66: Infectious Immunology, Australia, Revenue ($m) by Segment, Historic, 2002-2009 114
Figure 67: Infectious Immunology, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 116
Figure 68: Infectious Immunology, Australia, Company Share (%), 2009 119
Figure 69: Microbiology Culture, Market Segmentation 121
Figure 70: Microbiology Culture Market, Australia, Revenue Mix ($m), 2009 122
Figure 71: Microbiology Culture Market, Australia, Category Contribution (%), 2009 123
Figure 72: Microbiology Culture, Australia, Revenue ($m) by Segment, Historic, 2002-2009 124
Figure 73: Microbiology Culture, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 126
Figure 74: Microbiology Analyzers, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 128
Figure 75: Microbiology Analyzers, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 129
Figure 76: Microbiology Culture, Australia, Company Share (%), 2009 131
Figure 77: F. Hoffmann-La Roche Ltd., Company Share (%), Australia In Vitro Diagnostics Market, 2009 132
Figure 78: Siemens Healthcare, Company Share (%), Australia In Vitro Diagnostics Market, 2009 133
Figure 79: Abbott Laboratories, Company Share (%), Australia In Vitro Diagnostics Market, 2009 134
Figure 80: Beckman Coulter, Inc., Company Share (%), Australia In Vitro Diagnostics Market, 2009 135
Figure 81: Sysmex Corporation, Company Share (%), Australia In Vitro Diagnostics Market, 2009 136
Figure 82: bioMerieux S.A., Company Share (%), Australia In Vitro Diagnostics Market, 2009 137
Figure 83: GlobalData Methodology 184
[Fade out list of tables / figures]